Cancer drug makers seek 50% price hike
POST FORWARDED
April 05, 2026
Mumbai | Delhi: Manufacturing of cancer medicines such as carboplatin, oxaliplatin and cisplatin has become unviable due to a surge in the p...
Read more
from Economic Times https://ift.tt/dNR5QL9